SOURCE: Almac Clinical Technologies

March 12, 2007 08:30 ET

Almac Clinical Technologies at Top Clinical Trial Conferences

Company Presents on Adaptive Trial Design & EDC Industry Challenges

YARDLEY, PA -- (MARKET WIRE) -- March 12, 2007 -- Almac Clinical Technologies will be presenting at three major clinical conferences over the next two months. Eva Miller, Head of Biostatistics at Almac's facility in Yardley, PA, is due to speak at two upcoming DIA conferences: DIA Clinical Data Management and the 19th Annual DIA Euromeeting. In addition, Fritz Haas, VP of New Products at Almac Clinical Technologies, will speak at the 11th annual EDC & Beyond conference at Rosen Shingle Creek, Orlando, Florida in early April.

Dr. Miller will give an in-depth presentation at each event on the administration of flexible dosing and the implementation of adaptive randomisations. Almac Clinical Technologies is at the forefront of adaptive trial design. Dr Miller said: "Adaptive trial design is becoming more and more important as the demands of various licensing agencies become more prescriptive and demanding. At Almac, we are ahead of the curve, and across the world others are keen to hear what our company is doing."

Mr. Haas will share his thoughts on overcoming the challenges associated with developing a comprehensive view of clinical data using EDC. This session will explore the core technologies that comprise EDC systems, the critical upstream and downstream data integrations, along with the essential ingredients for a successful EDC solution. Mr. Haas notes, "The ability to view and work with integrated data has become increasingly important in Clinical Trials. Knowing how to develop and utilize this capability is more critical than ever, and EDC systems are at the heart of the matter." Almac's product, iTrialEDC™, has proven its reliability over the course of more than 10 years of use by investigative sites worldwide.

About Almac

Almac Clinical Technologies is a division of Almac that specialises in interactive technology and service solutions to increase the quality and efficiency of the clinical trial process. Our solutions include Interactive Voice and Web Response Systems (IXRS™) for patient randomization, tracking and clinical supply management, iDiary for phone and web-based electronic patient reported outcome data collection, and iTrial EDC for electronic case report form data collection.

Almac and its affiliated companies (Almac Diagnostics, Almac Sciences, Almac Clinical Services, Almac Clinical Technologies and Almac Pharma Services) provide a broad range of services across drug discovery, diagnostics, pharmaceutical research and development, manufacture of API, clinical trials and drug product manufacture. US operations are based in Pennsylvania, North Carolina and California. European operations are headquartered in Craigavon, Northern Ireland with additional operations in London and Edinburgh.

Contact Information

  • Contact:
    Meghan Adams
    US: 267-685-4284
    Email Contact

    Carl Whyte
    Stakeholder Communications
    02890 339949 / 00353 86 8679035